Fife company raises £4M to manufacture novel Covid-19 treatment
Pneumagen Ltd, a spin-off company of University of St Andrews has been awarded £4 million investment from Thairm Bio (Â...
Tag: Pneumagen
Drug developed by St Andrews spin out company targets COVID-19
A new anti-viral drug developed by Pneumagen, a University of St Andrews spin out company, has had positive results in ...